Deloitte's Conquering Cancer XPRIZE 'Ready to Launch'
Monday, October 10, 2016
At this year’s Visioneers 2016 Summit, XPRIZE convened nine international teams to share their Impact Design Proposals across a portfolio of Grand Challenge areas. Deloitte's Conquering Cancer XPRIZE, co-led by Deloitte health leaders and pediatric oncologist Dr. Daniel Kraft, received the "ready to launch” approval.
A group of 250 mentors, composed of prominent corporate and political leaders, entrepreneurs, philanthropists, artists, technologists and scientists, evaluated and critiqued nine XPRIZE proposals at the summit.
The Deloitte team's success means that it can now pursue the creation of an XPRIZE, incenting the development of an early diagnosis cancer screening tool – similar to a pregnancy test – to detect cancer early for everyone, everywhere. The other two ready-to-launch prizes address ALS and avatars.
"The team's prize design is based on a 'Match.com'-type platform to connect the ecosystem of researchers, managed care organizations, survivors, patients and physicians with nontraditional ones such as the consumer products industry, inventors and garage tinkerers," said Beth Meagher, principal, Deloitte Consulting LLP, and a Conquering Cancer XPRIZE team leader. "The platform can drive collaboration and break down silos as well as provide access to resources for rapid prototyping and aligns incentives with a substantial purse for the winning XPRIZE team."
"This XPRIZE will catalyze the crowd from expected and unexpected places," said Kraft. "From biotechnologists to DIY makers, data scientists and engineers can come together and collaborate while leveraging new technologies, systems, and mindsets to develop novel ways of detecting cancers rapidly, at low-cost, for everyone on the planet, from Tennessee to Tanzania."
"The magic of our approach is the bringing together some of the best minds in cancer detection with citizen scientists, ethnographers, and anyone from any background with a talent willing to make a contribution – and a difference," said Asif Dhar, principal, Deloitte Consulting LLP, and a Conquering Cancer XPRIZE team leader. "We would expect participants of our challenge to use exponential technologies that are ready and available – such as nanoscience, genomics, to artificial intelligence to smartphones and beyond."